SFB NYSE Week ended 31 Jul 2026

Weekly Investor Report

Stifel Financial Corporation 5.20% Senior Notes due 2047 · Other · Other

Open interactive chart View report data
Latest close 19.72 USD
0.0% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -0.4% below the Trend Line and sits at 22.7% of its 52-week range. The latest completed week returned 0.0%, after a 0.1% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.

Setup score 42 out of 100
Latest Close 19.72 USD 31 Jul 2026
1W Return 0.0% latest completed week
4W Return 0.1% short-term follow-through
12W Return -1.2% quarterly tape
Trend Breadth 38.5% 20 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.0% Latest completed week; four-week move 0.1%. Indicator stack 21/58 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 50/100 45 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -0.4% below the Trend Line and sits at 22.7% of its 52-week range. The latest completed week returned 0.0%, after a 0.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1812-week average 0.09

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.18Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 0.1% over four weeks, -1.2% over 12 weeks, and -1.2% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W0.0%
4W0.1%
12W-1.2%
26W-3.0%
52W-1.2%
Active trend streak0 weeks
Active weeks in one year20
Trend breadth38.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.40Latest activity-pressure read.
Pressure change11.3%Four-week change in activity pressure.
Leadership-10.30Latest relative-leadership reading.
RS change9.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength91/100Blend of value, momentum, and quality. Underlying universe rank 10; rank 1 is best.
Value99/100Relative valuation strength. Underlying universe rank 2; rank 1 is best.
Quality82/100Profitability and accounting quality. Underlying universe rank 19; rank 1 is best.
Momentum28/100Medium-term price momentum. Underlying universe rank 73; rank 1 is best.
Growth67/100Revenue and earnings growth. Underlying universe rank 34; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
3.7x
Price divided by trailing earnings.
Price / sales
0.5x
Market value relative to trailing revenue.
EV / EBITDA
1.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
104.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
92.6%
Gross profit retained from each unit of revenue.
Operating margin
25.9%
Operating profit retained from revenue.
Free-cash-flow margin
16.5%
Free cash flow generated from revenue.
Return on invested capital
33.8%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
5.0%
Latest one-year revenue growth.
EPS growth
42.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
61.9%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
3.3%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
3.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-2.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity15 / 5

15 acquisitions and 5 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment50/100

Weighted news tone is neutral across 45 relevant articles.

4 positive · 37 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-9.1%Distance below the 52-week high.
13-week volatility0.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+1.7%Week of 10 Apr.
Worst week-1.8%Week of 13 Mar.
Latest week+0.0%Week of 31 Jul.

Shape of recent returns

Strong gains0
Modest gains13
Flat weeks0
Modest losses13
Sharp losses0
Recent vol0.8%13-week weekly-return volatility.
Base vol1.2%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew0.9% / -0.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape39/100

Trend, activity pressure, participation, and risk combine to a 39/100 tape read.

 Indicator analysis24/100

Latest 12-week confirmation: trend 0/12, activity pressure 7/12, relative leadership 0/12.

Activity pressure 0.18; No reversal markers Factors76/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Cornerstone Growth rank 69; Buyback Yield rank 67; Small Cap Core rank 3 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 45 relevant articles.

AU SFB gains 5% after Q1 profit jumps 37%; JM Financial upgrades to 'Buy' Insiders15 / 5

15 acquisitions and 5 disposals in the latest 180-day insider tape.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202619.72 USD0.0%19.80 USD19.59 USD0.40-10.3049.6KOff
24 Jul 202619.71 USD-0.1%19.82 USD19.57 USD0.56-9.7185.1KOff
17 Jul 202619.74 USD1.1%19.83 USD19.57 USD0.54-10.3562.6KOff
10 Jul 202619.52 USD-0.9%19.86 USD19.56 USD0.42-13.0541.0KOff
3 Jul 202619.70 USD0.9%19.89 USD19.56 USD0.36-11.43100.8KOff
26 Jun 202619.53 USD0.1%19.92 USD19.55 USD0.06-10.6496.9KOff
19 Jun 202619.50 USD0.9%19.96 USD19.55 USD-0.22-13.2748.7KOff
12 Jun 202619.33 USD0.2%20.00 USD19.55 USD-0.33-13.7058.0KOff
5 Jun 202619.30 USD-1.0%20.04 USD19.55 USD-0.31-13.7365.1KOff
29 May 202619.50 USD-0.1%20.09 USD19.55 USD-0.24-15.3735.1KOff
22 May 202619.52 USD-0.9%20.14 USD19.55 USD-0.08-14.4450.8KOff
15 May 202619.70 USD-1.3%20.20 USD19.54 USD0.10-13.2835.3KOff
8 May 202619.96 USD0.8%20.25 USD19.53 USD0.07-12.2748.7KOff
1 May 202619.80 USD-1.7%20.29 USD19.53 USD-0.18-11.3992.3KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.